DANIELA AGUILERA BREMER: Open Payments
NPI 1780123083 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 24 payments from 10 companies in 2025. Trend: 2023 $707 · 2024 $572 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 6 | $177 |
| ABBVIE INC. | 5 | $123 |
| Insmed, Inc. | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Boston Scientific Corporation | 1 | $36 |
| La Jolla Pharmaceutical Company | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Shionogi Inc | 1 | $23 |
| Octapharma USA, Inc. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
Products named: CABENUVA, DALVANCE, Arikayce, LIVTENCITY, General - Embolics, XACDURO, DOVATO, OJJAARA.
Industry payments across MA — which companies pay providers there.
